Tag: CVnCoV
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
WACKER to manufacture CureVac’s COVID-19 vaccine candidate in Amsterdam
German biotech firm CureVac and Wacker Chemie AG have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
CureVac is a biopharmaceutical...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
